Table 3 Hazard ratios for psoriasis in the regional breast cancer cohort according to treatment characteristics
Total no. | No. of cases | HR (95% CI) | ||
|---|---|---|---|---|
Model 1 | Model 2 | |||
Endocrine therapy | ||||
No | 1533 | 27 | 1.00 (Ref.) | 1.00 (Ref.) |
Yes | 7100 | 121 | 0.90 (0.59–1.36) | 0.80 (0.52–1.24) |
Chemotherapy | ||||
No | 5544 | 102 | 1.00 (Ref.) | 1.00 (Ref.) |
Yes | 3070 | 46 | 0.82 (0.57–1.19) | 0.70 (0.47–1.04) |
Radiotherapy | ||||
No | 2061 | 23 | 1.00 (Ref.) | 1.00 (Ref.) |
Yes | 6574 | 125 | 1.78 (1.14–2.78) | 2.44 (1.44–4.12) |
Surgery | ||||
Lumpectomy | 5203 | 94 | 1.00 (Ref.) | 1.00 (Ref.) |
Mastectomy | 3459 | 55 | 0.96 (0.69–1.34) | 1.54 (1.03–2.31) |